Meetings: National Institute of Allergy and Infectious Diseases,

[Federal Register: June 4, 1998 (Volume 63, Number 107)]

[Notices]

[Page 30507]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr04jn98-78]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

Pursuant to Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following National Institute of Allergy and Infectious Diseases Special Emphasis Panel (SEP) meeting:

Name of SEP: Unnate Immunity in Vertebrates and Insects and Innate Immune Response to Microbial Infections.

Date: June 26, 1998.

Time: 8:30 a.m. to Adjournment.

Place: Bethesda Ramada Hotel and Conference Center, Parlor Room, 8400 Wisconsin Avenue, Bethesda, MD 20814, (301) 496-2550.

Contact Person: Dr. Vassil Georgiev, Scientific Review Admin., 6003 Executive Boulevard, Solar Bldg., Room 4C04, Bethesda, MD 20892, (301) 496-8206.

Purpose/Agenda: To evaluate grant applications.

The meeting will be closed in accordance with the provisions set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. Applications and/or proposals and the discussions could reveal confidential trade secrets or commercial property such as patentable material and personal information concerning individuals associated with the applications and/or proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Programs Nos. 93.855, Immunology, Allergic and Immunologic Diseases Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health)

Dated: May 27, 1998. LaVerne Y. Stringfield, Committee Management Officer, NIH.

[FR Doc. 98-14762Filed6-3-98; 8:45 am]

BILLING CODE 4140-01-M

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT